AbbVie Inc.
ABBV
|
News
|
$169.54
0.98%
-0.91%
4.1M
|
Health Technology
(0.0% 1d) (-5.0% 1m) (2.8% 1y) (0.0% 2d) (1.0% 3d) (2.7% 7d) (-26.82% volume)
Earnings Calendar:
Market Cap: $ 300,195,489,498
http://www.abbvie.com
Sec Filling | Patents | 30000 employees
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
cancer hiv autoimmunity hepatitis fibrosis metabolic parkinson neurological
Drugs
Alcohol - Hand Sanitizer (Alcohol)Androgel (Testosterone)
Creon (Pancrelipase)
Depakote (Divalproex Sodium)
Depakote ER (Divalproex Sodium)
Depakote Sprinkles (Divalproex Sodium)
Duopa (Carbidopa and Levodopa)
Gengraf (Cyclosporine)
Humira (Adalimumab)
Kaletra (Lopinavir and Ritonavir)
K-Tab (Potassium Chloride)
Lupaneta Pack (leuprolide acetate and norethindrone acetate)
Lupron Depot (leuprolide acetate)
Lupron Depot-PED (leuprolide acetate)
Marinol (Dronabinol)
Mavyret (Glecaprevir and Pibrentasvir)
Niaspan (Niacin)
Nimbex (Cisatracurium besylate)
Norvir (Ritonavir)
Oriahnn (Elagolix and Estradiol and Norethisterone)
Orilissa (Elagolix)
Rinvoq (Upadacitinib)
Skyrizi (Risankizumab-rzaa)
Survanta (Beractant)
Synthroid (Levothyroxine Sodium)
Tarka (Trandolapril and Verapamil Hydrochloride)
Tricor (Fenofibrate)
Trilipix (Fenofibric Acid)
Ultane (Sevoflurane)
Venclexta (Venetoclax)
Viekira Pak (Dasabuvir and Ombitasvir and Paritaprevir and Ritonavir)
Zemplar (Paricalcitol)
add to watch list Paper trade email alert is off
Press-releases
Solar Photovoltaic Market size is set to grow by USD 47.16 billion from 2023-2027, ABB Ltd., All Earth Renewables and Canadian Solar Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 23:00) - prnewswire.com
ABBNY | News | $48.5 4.05% 200K
|
n/a
|
| O: 0.1%
H: 0.82%
C: 0.68%
ABLZF | News | $50.158 -32.74% 1.9K
|
Producer Manufacturing
|
| O: -3.15%
H: 3.29%
C: -0.41%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.42%
H: 1.06%
C: 0.56%
CSIQ | News | $14.88 -0.6% -0.6% 2.1M
|
Producer Manufacturing
|
| O: 1.6%
H: 2.83%
C: -2.24%
photovoltaic solar set key market
HIV Drugs Market size is set to grow by USD 10.47 billion from 2023-2027, AbbVie Inc., Aspen Pharmacare Holdings Ltd and Aurobindo Pharma Ltd., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: -3.15%
H: 0.0%
C: -0.61%
VTRS | News A | $11.36 0.98% 0.97% 4.7M
|
Health Technology
|
| O: 0.0%
H: 1.33%
C: 0.98%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.17%
H: 1.48%
C: 1.43%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.42%
H: 1.06%
C: 0.56%
pharma abbvie set hiv key market
Recreational Boats Market size is set to grow by USD 5.63 billion from 2023-2027, A. H. Wadia Boat Builders, Azimut Benetti SpA and Baja Marine, and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 23:00) - prnewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.42%
H: 1.06%
C: 0.56%
set key boats spa market
Lighting Market size is set to grow by USD 54.76 billion from 2024-2028, Acuity Brands Inc., ams OSRAM AG and Bridgelux Inc., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 23:00) - prnewswire.com
PHG | News | $21.01 1.94% 0.0% 2M
|
Health Technology
|
| O: 0.53%
H: 1.54%
C: 1.4%
HUBB | News | $398.0 1.91% 0.0% 260K
|
Producer Manufacturing
|
| O: 0.75%
H: 1.77%
C: 1.14%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.42%
H: 1.06%
C: 0.56%
LYTS | News | $14.52 0.0% 87K
|
Producer Manufacturing
|
| O: 0.21%
H: 1.31%
C: -0.21%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.08%
H: 0.86%
C: 0.51%
brands set key market
Injection Molding Market size is set to grow by USD 30.65 billion from 2023-2027, All Plastics LLC, Biomerics LLC and BORCHE North America INC., and more to emerge as Some of the Key Vendors, Technavio
Published: 2024-04-22 (Crawled : 23:00) - prnewswire.com
ADRZY | News | $12.02 -17.72% 510
|
Manufacturing
|
| O: -2.91%
H: 1.8%
C: 1.8%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.42%
H: 1.06%
C: 0.56%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.08%
H: 0.86%
C: 0.51%
america set key injection market
Phase 3 SELECT-GCA Study of Upadacitinib (RINVOQ®) Showed Positive Results in Patients With Giant Cell Arteritis
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
rinvoq positive cell results study
Pulmonary Embolism Therapeutics Market size to grow at a CAGR of 9.52% from 2022 to 2027, Technavio
Published: 2024-04-17 (Crawled : 00:00) - prnewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
therapeutics market
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published: 2024-04-15 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.75%
H: 0.85%
C: 0.85%
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: -2.52%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -1.46%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -1.19%
H: 0.52%
C: -0.17%
BAX | $41.02 1.54% 0.0% 2.6M
|
Health Technology
|
| O: -0.1%
H: 0.13%
C: -1.08%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.32%
H: 0.96%
C: 0.22%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -2.13%
H: 0.0%
C: 0.0%
BMRN | $92.06 2.87% 2.79% 1.3M
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.04%
AMGN | News | $273.69 0.66% 0.65% 2.5M
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
set therapeutics market
Gastrointestinal Therapeutics and Diagnostics: Propelling Global Markets with Cutting-Edge Technologies by BCC Research LLC
Published: 2024-04-15 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.13%
H: 0.11%
C: -1.73%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
research global gastrointestinal therapeutics
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: 0.0%
qulipta abbvie treatment for migraine
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
MEGI | $11.975 1.87% 0.04% 140K
|
|
00:30
CTRN P 29000 | $22.25 0.14% 0.13% 100K
|
Retail Trade
|
22:00
CONN | $3.71 1.37% 1.35% 72K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.6897 39.71% 2.3K
|
Utilities
|
18:30
CMTV P 700 | $15.74 17.43% 12K
|
Finance and Insurance
|
18:30
FNB | $13.63 2.17% 0.0% 2.5M
|
Finance
|
17:30
RMCF | $3.57 0.28% 2.8K
|
Consumer Non-Durables
|
20:10